Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 4/7/15  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Gary L. Crocker

Wrong Gary L. Crocker?

President

Phone: (801) ***-****  HQ Phone
Crocker Ventures
2825 Cottonwood Pkwy Ste 330
Salt Lake City , Utah 84121
United States

Company Description: Crocker Ventures is an independent, privately-held life science and healthcare investment firm that funds promising seed- and early-stage life science technology...   more
Background

Employment History

  • Chairman
    Utah Youth Village
  • Member of the President's Leadership Council
    Brigham Young University
  • Chairman
    ARUP Laboratories Inc
  • President and Chief Executive Officer and Founder
    Research Medical
  • Co-Founder and Director
    TheraTech
  • Founding Director and Original Investor
    TheraTech
  • Vice President for Business Development
    Sorenson Research Company
  • Vice President of Business Development and Director of Marketing
    Sorenson Research Company
  • President of the Board
    Utah Opera Company
  • Chairman and Chief Executive Officer
    TrainSeek , Inc.
  • Chairman, Chief Executive Officer, Director
    TrainSeek , Inc.
  • Chairman and Initial Investor
    TrainSeek , Inc.

Board Memberships and Affiliations

  • Founder
    Crocker Ventures
  • Board Member
    Federal Reserve Branch of San Francisco
  • Board Member
    Interleuken Genetics
  • Board Member
    LineaGen Genetics , LLC.
  • Founder
    Research Medical
  • Board Member
    TheraTech

Education

  • B.S.
    Harvard College
  • M.B.A.
    Harvard Business School
  • B.S. , economics
    Harvard University
  • M.B.A.
    Harvard University
  • Bachelor of Science degree , Economics
    Harvard University
136 Total References
Web References
Crocker Ventures | Gary L. Crocker
www.crockerventures.com, 7 April 2015 [cached]
Gary L. Crocker Crocker Ventures | Gary L. Crocker
Crocker Ventures
...
Gary L. Crocker
...
Gary Crocker: Product, Long Term Job and Value Creation, and Funding are Critical Keys to Sustainable Utah Companies Press Room Contact Us
Home / About Us / Gary L. Crocker
...
Gary L. Crocker
Gary L. Crocker is president of Crocker Ventures, an independent, privately held life science and healthcare investment firm that funds promising seed- and early-stage life science companies. He is also chairman of Merrimack Pharmaceuticals, an innovative and rapidly-growing predictive medicine oncology drug company. In September 2009, Merrimack-a major Crocker Ventures investment-closed one of the largest recent "single drug" transactions in the biotech industry, a half-billion dollar licensing deal with Sanofi-Aventis. The agreement illustrates the investment approach Mr. Crocker has developed and refined, and upon which he founded Crocker Ventures: aggressive, experience-driven operations underpinned by a commitment to innovation and a willingness to take risk.
During his productive 30-plus-year career, Mr. Crocker has founded and led an array of innovative health care and life science firms that have established global leadership in strategic industry niches. He has served as chairman of ARUP Laboratories, director of Interleuken Genetics and LineaGen Genetics LLC, and co-founder and director of Theratech, which was acquired in 1999 by Watson Pharmaceuticals. Mr. Crocker was the founder of Research Medical, Inc., a manufacturer and marketer of specialty cardiac catheters and related medical devices utilized in open heart surgeries that was acquired by Baxter International in 1997 in what was the largest medical device merger in Utah history. He has been named Entrepreneur of the Year for Utah by both Ernst & Young and the MountainWest Capital Network. Mr. Crocker received his BA and MBA from Harvard University.
To view downloadable photos and an expanded biography of Mr. Crocker, visit our online press room.
Utah Youth Village - Leadership / Alpine Academy
www.youthvillage.org, 9 Feb 2015 [cached]
Gary L. Crocker Chairman of the Board
Gary L. Crocker is a self-made man, a nationally recognized entrepreneur, and a man with a deep conviction to serve mankind.
He is President of Crocker Ventures, LLC, a venture investment firm focusing on healthcare and medical technologies. He is the current Chairman of the Board for Merrimack Pharmaceuticals and the former Chairman of the Board for ARUP Laboratories in Research Park and past President and CEO of Research Medical, Inc., which he founded in 1983. Forbes magazine recognized his firm for six consecutive years as one of "America's Best 200 Small Companies. He was one of the original investors in Theratech, Inc., and served as Vice President for Business Development for Sorenson Research. He was awarded Utah's "High Technology Entrepreneur of the Year" in 1994 and "Utah's Entrepreneur of the Year" in 1999.
Gary has served as the Chairman of the Board for Utah Youth Village for twelve years, leading the Village to unprecedented growth in its ability to serve Utah's abused, neglected, and troubled children. His dedication to the Village's program for troubled families, Families First, led to a major gift which is enabling the Village to serve hundreds of struggling low-income families. Additionally, he and his wife Ann, made a major gift to Utah Youth Village's Alpine Academy Education Center, providing a spacious and inspiring place for young girls to learn academically and grow socially.
Gary is the Vice Chairman for the University of Utah Board of Trustees. The Crockers recently contributed a major gift toward the renovation of Ft. Douglas, underwriting the renovation of a home on the Officers Circle which will eventually house 12 outstanding math and science students.
Gary is also a member of the President's Leadership Council at Brigham Young University, in which he played a pivotal role both as a major donor and as a volunteer leader in their recent capital campaign.
He also served as President of the Board for the Utah Opera Company, where he introduced their highly successful Med Night. He is a former trustee of the Deseret Foundation's Heart-Lung Research Institute.
Gary earned his MBA from the Harvard Business School and a Bachelor of Science degree from Harvard College, where he garnered magna cum laude honors in economics. He and his wife, Ann, have seven children and were honored with the Next Generation Spirit of Giving Award at the Utah 2001 Philanthropy Day.
Management
www.nanoinjectiontech.com, 11 May 2014 [cached]
Gary L. Crocker, Managing Member
Gary Crocker is the Managing Member of NanoInjection Technologies. He is also President of Crocker Ventures, is chairman of Merrimack Pharmaceuticals, and recently completed his second term on the Board of Directors of the Federal Reserve Branch of San Francisco. During his productive 30-plus-year career, Mr. Crocker has founded and led an array of innovative health care and life science firms that have established global leadership in strategic industry niches. He has served as chairman of ARUP Laboratories, director of Interleuken Genetics and LineaGen Genetics LLC, and co-founder and director of Theratech, which was acquired in 1999 by Watson Pharmaceuticals. Mr. Crocker was the founder of Research Medical, Inc., a manufacturer and marketer of specialty cardiac catheters that was acquired by Baxter International in what was the largest medical device merger in Utah history. He has been named Entrepreneur of the Year for Utah by both Ernst & Young and the MountainWest Capital Network. He has been inducted into the Utah Technology Council Hall of Fame, the University of Utah Science Hall of Fame, and serves as a director of the University of Utah's Research Foundation. He has BA and MBA degrees from Harvard University.
Gary L. Crocker is the ...
www.iclrs.org, 16 Mar 2014 [cached]
Gary L. Crocker is the Chairman of Merrimack Pharmaceuticals, a privately held biotech firm based in Cambridge, Massachusetts that develops diagnostic tests and novel drugs for cancer treatment. Mr. Crocker is President of Crocker Ventures, LLC, a life science private investment firm. He is in the midst of his second term on the Board of Directors of the Federal Reserve Branch of San Francisco and also serves as a member of the Advisory Board of Sorenson Capital, an LBO private equity fund. He has held senior executive or director level positions in several successful life science firms including service from 1998 to 2003 as Chairman of ARUP Laboratories, as a director of Interleuken Genetics, Inc, and LineaGen Genetics, LLC., and as a co-founder and director of Theratech, Inc. which was acquired in 1999 by Waton Pharmaceuticals. From 1983 to 1997, he was President/CEO and founder of Research Medical, Inc., a publicly traded cardiac device manufacturer acquired by Baxter International in 1997. Prior to Research Medical, Mr. Crocker was Vice President, Business Development and Director of Marketing for the Sorenson Research division of Abbott Laboratories, and an Internal Strategic Analyst for Baxter International. He was recently inducted into the University of Utah Science Hall of Fame, and he serves as a director of the University's Research Foundation. Mr. Crocker earned his MBA and also graduated magna cum laude with a Bachelor of Science degree in Economics from Harvard University.
Pharmaceutical Processing
www.pharmpro.com, 11 May 2005 [cached]
Merrimack Pharmaceuticals Appoints Gary L. Crocker as Chairman of the Board
Merrimack Pharmaceuticals, Inc., a biotechnology company focused on the discovery and development of pioneering treatments for autoimmune diseases and cancer, recently announced that it has elected Gary L. Crocker as chairman of its board of directors.Mr. Crocker was initially elected to the Merrimack board in 2004, when he participated in the company's $28 million Series C funding round.
Mr. Crocker comes to his new role at Merrimack with more than 25 years' successful experience funding, growing and leading companies in the biotechnology and medical device industries.He was founder and president of Research Medical, a publicly traded manufacturer of cardiac catheters and other open heart surgery devices that was recognized by Forbes magazine for six consecutive years as one of "America's 200 Best Small Growth Companies," and acquired in 1997 by Baxter International, one of the world's largest device companies.Mr. Crocker was also a founding director and original investor in TheraTech, a successful drug delivery company purchased by Watson Pharmaceutical in 1999.
Mr. Crocker currently serves as CEO and chairman of AnzenBio, a Salt Lake City, Utah-based developer of field-deployable, electrochemical pathogen detection systems for biologicals, toxins and nucleic acids, as well as nucleic acid isolation and amplification devices.He is also president of Crocker Ventures, an early stage investment firm focused on life sciences technologies, and is a current investor in several companies, including Merrimack.
Mr. Crocker also has extensive board experience.From 1998 to 2003 he served as chairman of ARUP, one of the nation's largest esoteric diagnostic test laboratories.In addition to Merrimack, Mr. Crocker currently serves as a director on the boards of the Salt Lake City branch of the Federal Reserve Bank of San Francisco; GenData, LLC; and on the advisory board of Sorenson Capital, LLC, a $250 million dollar venture investmentfirm.
"Gary Crocker has proven to be an outstanding director who brings to Merrimack a wealth of knowledge and expertise in the growth and development of successful life science ventures," said Robert Mulroy, president and CEO of Merrimack Pharmaceuticals.
...
Mr. Crocker assumes board leadership of Merrimack at a time of significant growth and opportunity for the company.Merrimack completed a $37 million Series D equity and debt financing round on April 20, 2005, and the company recently initiated Phase II clinical development trials for its lead compound, MM-093, for the treatment of rheumatoid arthritis.
"I am confident that Merrimack has the capacity to make fundamental contributions in the therapeutic arenas of autoimmune disease treatment and cancer treatment," said Mr. Crocker.
Other People with the name "Crocker":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.